Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5879 posts found.

epidiolex-100mg-carton-bottle-unenhanced-0074c-j10

GW Pharma applies to both EU and US for lead product

January 2, 2018 Manufacturing and Production, Sales and Marketing GW Pharma, biotech, drugs, pharma, pharmaceutical

GW Pharmaceuticals had a busy festive period, after it announced that it had submitted to both the EU and the …
News
Pfizer headquarters

NICE to take another look at Pfizer’s leukaemia drug

January 2, 2018 Manufacturing and Production, Sales and Marketing NICE, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in August of 2017, NICE rejected Pfizer’s Besponsa on cost-effectiveness grounds and the pharma giant was not best pleased. …
News
dermapace-product

FDA approves shock wave wound healing device

January 2, 2018 Manufacturing and Production, Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical

Continuing its recent trend to promote innovative new technologies, the FDA has announced that it has approved a medical device …
News
mylan_building

Mylan and Biocon biosimilar approval expands to Brazil

January 2, 2018 Manufacturing and Production, Sales and Marketing Biocon, Herceptin, Mylan, biosimilar, biotech, drugs, pharma, pharmaceutical

Since Mylan and Biocon managed to gain US FDA approval for its Herceptin (Trastuzumab) biosimilar, it has forged ahead in …
News
valeant

Valeant and Pershing take $290m hit over insider trading

January 2, 2018 Manufacturing and Production, Sales and Marketing Bill Ackman, Pershing Square, Valeant, biotech, drugs, pharma, pharmaceutical

Valeant Pharmaceuticals will be hoping it can begin 2018 as a fresh start, after a turbulent few years, to say …
News
4420456374_64a3d7e6aa

Pharmafile.com’s top ten stories of 2017

December 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit

After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …
News
2018

Seven pharma trends for 2018

December 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

Pharmafile.com looks ahead to signpost what we expect will be the key industry trends through the course of 2018.The value of …
Feature
attribution-icon-2888829_640

The rare disease climate in Europe

December 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, rare disease

Continuing on from this week’s earlier feature on the rare disease situation in the US, Pharmafile moves its attention onto …
Feature
gsk_boronia_australia

GSK forced to pay back £1.5m to Scottish Government after recent job cuts

December 20, 2017 Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, pharma

British pharmaceutical giant GlaxoSmithKline has been ordered to pay back £1.5 million to the Scottish Government because of its failure …
News
allergan

Allergan and Gedeon Richter’s Vraylar posts strong Phase 3 data in bipolar depression

December 19, 2017 Manufacturing and Production, Research and Development Allergan, Gedeon Richter, Vraylar, bipolar, bipolar depression, pharma

Vraylar (cariprazine), a drug developed as part of a partnership between Allergan and Gedeon Richter, has demonstrated strong results at …
News

Boehringer scoops schizophrenia candidates for €627.5m

December 19, 2017 Manufacturing and Production, Sales and Marketing Autifony, Boehringer Ingelheim, biotech, drugs, pharma, pharmaceutical

Boehringer Ingelheim has moved early to secure an exclusive option on Autifony’s lead candidate for the treatment of schizophrenia, AUT00206, …
News
homeopathy-1063292_640

FDA pledges to crack down on homeopathy treatments

December 19, 2017 Manufacturing and Production, Sales and Marketing FDA homeopathy, US, pharma

Following in the steps of authorities in the European Union, Australia and the United Kingdom, the FDA has pledged to …
News
doctor-563428_960_720

100,000 vacancies contribute to NHS crisis

December 19, 2017 Manufacturing and Production, Medical Communications NHS, UK, biotech, drugs, nurses, pharma, pharmaceutical

Warning shots have been fired by both the General Medical Council (GMC) and the Labour Party about the recruitment issues …
News
novartis_window

Novartis snaps up Priority Review Voucher for $130m

December 18, 2017 Manufacturing and Production, Sales and Marketing Novartis, Ultragenyx, biotech, drugs, pharma, pharmaceutical

Novartis has got its wallet out to pick up a Priority Review Voucher (PRV) from Ultragenyx, forking out $130 million …
News
rare-disease-2888820_960_720

Rare disease medicines access faces a perfect storm

December 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, rare disease

With access to rare disease treatments coming under increasing attention, both in the EU and the US, Pharmafile.com took the …
Feature
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026